Health equity
The Impact of Patent Expirations
Imagine this: you’re a public health professional working tirelessly to ensure that patients get access to the best treatments available. You rely on cost-effectiveness analyses (CEAs) to guide your decisions, helping you navigate the complex terrain of drug pricing and healthcare resources. But what if the tools you rely on aren’t telling the whole story? […]
Read more →